We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Disputes WHO Finding that Remdesivir Had ‘Little or No Effect’ on Hospitalized COVID-19 Patients
Gilead Disputes WHO Finding that Remdesivir Had ‘Little or No Effect’ on Hospitalized COVID-19 Patients
Gilead Sciences has rejected early findings from the World Health Organization’s Solidarity trial showing four antivirals, including remdesivir, had “little or no effect” on hospitalized COVID-19 patients, criticizing the trial’s design and expressing concern that the data hadn’t gone through a peer review.